ManifoldResolved: YESBINARY · cpmm-1

Will Nuvalent (NUVL) stock gain more than 7% on Nov 17 upon topline data release for ALKOVE-1 Trial of Neladalkib?

Yes99%
Yes Pool
$10
No Pool
$995

Resolution

YES